Viable Cryopreservation Strategy for Extending the Timeframe of Circulating Tumor Cell Detection in Breast Cancer Clinical Trials
Circulating tumor cells (CTCs) hold recognized prognostic value in various cancers, including breast cancer, where their presence correlates with survival outcomes. However, the typical 24 h window for blood processing and CTC isolation poses a logistical challenge, particularly for multicenter stud...
Saved in:
| Main Authors: | Cristina Sánchez-Quesada, Estefanía Toledo, José Juan Jiménez-Moleón, José Juan Gaforio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/5/723 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential applications of gene expression profiles obtained from circulating extracellular vesicles in breast cancer
by: Aritra Gupta, et al.
Published: (2025-03-01) -
Circulating Micro-RNAs Predict the Risk of Recurrence in Triple-Negative Breast Cancer
by: Jouni Kujala, et al.
Published: (2024-11-01) -
Liquid biopsy through non-blood fluids: The show must go on
by: Angelo Dipasquale, et al.
Published: (2024-12-01) -
Prostate Biopsy: Is it Still Relevant Today?
by: Ritesh Goel, et al.
Published: (2025-04-01) -
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium
by: Andrew G. Hadd, et al.
Published: (2025-03-01)